Internal Medicine · Brooklyn, NY
NPI
1770616864
Since 2007
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
1508 Avenue U
Brooklyn, NY, 11229
Phone (917) 754-5781
Groups this clinician bills Medicare through
Medicare paid, 2024
$52K
2,987 services
Medicare patients, 2024
61
Average age 77
Drug cost, 2024
$7.3M
35,593 prescriptions
Company payments, 2025
$2,761
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Xian Min Li was code 99213 (office e&m - established), 225 times for 53 patients. In total Xian Min Li billed 2,987 services in 34 codes, and Medicare paid $52K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-03-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 225 | 53 | $73.97 | $17K |
| 99214 Office E&M - Established | Office | 87 | 43 | $88.15 | $7,669 |
| 36415 Venipuncture Blood Collection | Office | 59 | 42 | $8.65 | $510 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 56 | 27 | $14.55 | $815 |
| 99212 Office E&M - Established | Office | 49 | 25 | $46.52 | $2,279 |
| 99497 Care Management/Coordination | Office | 42 | 42 | $65.12 | $2,735 |
| 96127 Behavioral Health Services | Office | 38 | 31 | $4.20 | $160 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 33 | 33 | $147.40 | $4,864 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 28 | 28 | $21.68 | $607 |
| G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 25 | 17 | $36.90 | $923 |
| G0008 Administration of influenza virus vaccine | Office | 15 | 15 | $37.09 | $556 |
By year: 2022 $66K for 1,989 services; 2023 $56K for 6,230 services; 2024 $52K for 2,987 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 59 | 42 | $8.65 | $510 |
Medicare prescription drug claims, 2024
In 2024, the drug Xian Min Li prescribed most often to Medicare patients was Montelukast Sodium, with 1,455 prescriptions and refills. In total Xian Min Li wrote 35,593 Medicare prescriptions that cost $7.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 1,455 | 1,702 | 342 | $7,042 |
| Vascepa Icosapent Ethyl | 1,374 | 2,632 | 303 | $908K |
| Rosuvastatin Calcium Generic | 1,365 | 3,483 | 355 | $14K |
| Atorvastatin Calcium Generic | 955 | 2,524 | 262 | $9,868 |
| Diclofenac Epolamine Generic | 906 | 1,794 | 256 | $1.2M |
| Chlorhexidine Gluconate Generic | 830 | 1,017 | 296 | $5,785 |
| Fluconazole Generic | 773 | 775 | 378 | $7,969 |
| Ammonium Lactate Generic | 728 | 743 | 274 | $20K |
| Tamsulosin Hcl Generic | 718 | 1,878 | 201 | $8,287 |
| Amlodipine Besylate Generic | 714 | 1,768 | 188 | $5,396 |
| Omeprazole Generic | 693 | 797 | 192 | $6,444 |
| Memantine Hcl Generic | 600 | 1,600 | 234 | $10K |
| Famciclovir Generic | 576 | 576 | 325 | $13K |
| Azelastine Hcl Generic | 575 | 596 | 167 | $12K |
| Losartan Potassium Generic | 568 | 1,468 | 156 | $5,022 |
Brand drugs: 7,477 claims; generic drugs: 27,685 claims; opioid claims: 143.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Xian Min Li $2,761 ($2,761 in general payments such as food, travel and fees) from 19 companies. The largest payer was Abbvie Inc. with $425.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 20 | $425 |
| AstraZeneca Pharmaceuticals LP AZN | 14 | $304 |
| Amgen Inc. AMGN | 14 | $260 |
| Axsome Therapeutics, Inc. AXSM | 11 | $230 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 9 | $229 |
| Gilead Sciences, Inc. GILD | 12 | $216 |
| GlaxoSmithKline, LLC. GSK | 8 | $206 |
| Insmed, Inc. INSM | 8 | $178 |
| Sumitomo Pharma America, Inc. 4506.T | 8 | $155 |
| Pfizer Inc. PFE | 5 | $131 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.